Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan
- 31 December 2009
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 34 (6), 580-584
- https://doi.org/10.1016/j.ijantimicag.2009.06.027
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Acquisition of a Plasmid-Borne bla OXA-58 Gene with an Upstream IS 1008 Insertion Conferring a High Level of Carbapenem Resistance to Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2008
- Acinetobacter radioresistensas a Silent Source of Carbapenem Resistance forAcinetobactersppAntimicrobial Agents and Chemotherapy, 2008
- Therapeutic options forAcinetobacter baumanniiinfectionsExpert Opinion on Pharmacotherapy, 2008
- Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese HospitalsAntimicrobial Agents and Chemotherapy, 2007
- Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumanniiClinical Microbiology & Infection, 2007
- Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TUJournal of Antimicrobial Chemotherapy, 2007
- Distinct Antimicrobial Resistance Patterns and Antimicrobial Resistance-Harboring Genes According to Genomic Species of Acinetobacter IsolatesJournal of Clinical Microbiology, 2007
- Phenotypic Detection of Carbapenem-Susceptible Metallo-β-Lactamase-Producing Gram-Negative Bacilli in the Clinical LaboratoryJournal of Clinical Microbiology, 2006
- Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiologyClinical Microbiology & Infection, 2006
- Genetic Structures at the Origin of Acquisition and Expression of the Carbapenem-Hydrolyzing Oxacillinase Gene bla OXA-58 in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2006